Serious adverse reactions induced by minocycline: Report of 13 patients and review of the literature

Archives of Dermatology

Volumn 132, Issue 8, 1996, Pages 934-939

  Knowles, Sandra R ^a   Shapiro, Lori ^a   Shear, Neil H ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG MONITORING; DRUG SAFETY; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS; MALE; PRIORITY JOURNAL; REVIEW; SERUM SICKNESS;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MINOCYCLINE; RETROSPECTIVE STUDIES;

EID: 0029814852     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.132.8.934     Document Type: Review

References (38)

1. Sitbon O, Bidel N, Dusopt C, et al. Minocycline pneumonitis and eosinophilia: a report on eight patients. Arch Intern Med. 1994;154:1633-1640.
2. Kloppenburg M, Dijkmans B, Breedveld F. Hypersensitivity pneumonitis during minocycline treatment. Neth J Med. 1994;44:210-213.
3. Guillon J-M, Joly P, Autran B, et al. Mirocycline-induced cell-mediated hypersensitivity pneumonitis. Ann Intern Med. 1992;117:476-481.
4. Yokoyama A, Mizushima Y, Suzuki H, Arai N, Kitagawa M, Yana S. Acute eosinophilic pneumonia induced by minocycline: prominent Kerley B lines as a feature of positive re-challenge test. Jpn J Med. 1990;29:195-198.
5. Bando T, Fujimura M, Noda Y, Hirose J-I, Ohta G, Matsuda T. Minocycline-induced pneumonitis with bilateral hilar lymphadenophathy and pleural effusion. Intern Med. 1994;33:177-179.
6. Bridges A, Graziano F, Calhoun W, Reizner G. Hyperpigmentation, neutrophilic alveolitis, and erythema nodosum resulting from minocycline. J Am Acad Dermatol. 1990;22:959-962.
7. Davies M, Kersey P. Acute hepatitis and exfoliative dermatitis associated with minocycline. BMJ. 1989;298:1523-1524.
8. Boudreaux J, Hayes D, Mizrahi S, Hussey J, Regenstein F, Balart L. Fulminant hepatic failure, hepatorenal syndrome, necrotizing pancreatitis after minocycline hepatotoxicity. Transplant Proc. 1993;25:1873.
9. Burette A, Finet C, Prigogine T, De Roy G, Deltenre M. Acute hepatic injury associated with minocycline. Arch Intern Med. 1984;144:1491-1492.
10. Malcolm A, Heap T, Eckstein R, Lunzer M. Minocycline-induced liver injury. Hepatology. 1995;22:452A.
11. Mensing H, Kowalzick L. Acute febrile neutrophilic dermatosis (Sweet's syndrome) caused by minocycline. Dermatologica. 1991;182:43-46.
12. Thibault M-J, Billick R, Srolovitz H. Minocycline-induced Sweet's syndrome. J Am Acad Dermatol. 1992;27:801-804.
13. Inoue C, Kondo Y, Suwabe N, Igarashi Y, Tada K. Minocycline-related lupus in childhood. Eur J Pediatr. 1994;153:540.
14. Matsuura T, Shimizu Y, Fujimoto H, Miyazaki T, Kano S. Minocycline-related lupus. Lancet 1993;340:1553.
15. Byrne PAC, Williams BD, Pritchard MH. Minocycline-related lupus. Br J Rheu- matol. 1994;33:674-676.
16. Ouilty B, McHugh N. Lupus-like syndrome associated with the use of minocycline. Br J Rheumatol. 1994;33:1197-1198.
17. Bulgen D. Minocycline-related lupus. Dr J Rheumatol. 1995;34:398.
18. Gordon P, White M, Herriot R, Martin J, Reid D. Minocycline-associated lupus erythematosus. Br J Dermatol. 1995;132:120-121.
19. Gough A, Chapman S, Wagstaff K, Emery P, Elias E. Minocycline-induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ 1996;312:169-172.
20. Gendi N, Bowman S, Mowat A. Lupus-like syndrome in patients treated for acne. Br J Rheumatol, 1995;34:584-585.
21. Puyana J, Urena V, Quirce S, Fernandez-Rivas M, Cuevas M, Fraj J. Serum sickness-like syndrome associated with minocycline therapy. Allergy. 1990;45:313-315.
22. Kaufmann D, Pichler W, Beer J. Severe episode of high fever with rash, lymphadenopathy, neutropenia, and eosinophilia after minocycline therapy for acne. Arch Intern Med. 1994;154:1983-1984.
23. Min DI, Burke PA, Lewis WD, Jenkins RL. Acute hepatic failure associated with oral minocycline: a case report. Pharmacotherapy. 1992;12:68-71.
24. Wilkinson S, Stewart W, Spiers E, Pears J. Protracted systemic illness and interstitial nephritis due to minocycline. Postgrad Med J. 1989;65:53-56.
25. Chatham W, ROSS D. Leukemoid blood reaction to tetracycline. South Med J. 1983;76:1195-1196.
26. Parneix-Spake A, Bastuji-Garin S, Lobut J, et al. Minocycline as possible cause of severe and protracted hypersensitivity drug reaction. Arch Dermatol. 1995; 131:490-491.
27. Recchia A, Shear N. Organization and functioning of an adverse drug reaction clinic. J Clin Pharmacol. 1994;34:68-79.
28. ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Health Syst Pharm. 1995;52:417-419.
29. Yung R, Richardson B. Drug-induced lupus. Rheum Dis Clin North Am. 1994; 20:61-86.
30. Minocin: recently reported serious reactions. Can Adverse Drug React Newslett. August 1991;1:1, 3.
31. Roujeau J. Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol. 1987;123:1171-1173.
32. Gupta A, Eggo M, Uetrecht J, et al. Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides. Clin Pharmacol Ther. 1992;51:56-67.
33. Shear N, Spielberg S. Anticonvulsant hypersensitivity syndrome, in vitro assessment of risk. J Clin Invest. 1988;82:1826-1832.
34. Rieder M, Uetrecht J, Shear N, Cannon M, Miller M, Spielberg S. Diagnosis of suffonamide hypersensitivity reactions by in-vitro 'rechallenge' with hydroxylamine metabolites. Ann Intern Med. 1989;110:286-289.
35. De Vriese A, Philippe J, Van Renterghem D, et al. Carbamazepine hypersensitivity syndrome: report of four cases and review of the literature. Medicine. 1995;74:144-151.
36. Kearns G, Wheeler J, Childress S, Letzig L. Serum sickness-like reactions to cefaclor: role of hepatic metabolism and individual susceptibility. J Pediatr. 1994;125:805-811.
37. Wolkenstein P, Revuz J. Drug-induced severe skin reactions: incidence, management and prevention. Drug Safety. 1995;13:56-68.
38. Driscoll M, Rothe MJ, Abrahamian L, Grant-Kels JM. Long-term oral antibiotics for acne: is laboratory monitoring necessary? J Am Acad Dermatol. 1993; 28:595-602.